PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1981 February; 43(2): 169–176.
PMCID: PMC2010513

Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study.

Abstract

A number of men with malignant lymphoma of the histiocytic type and previous exposure to phenoxy acids or chlorophenols were observed and reported in 1979. A matched case-control study has therefore been performed with cases of malignant lymphoma (Hodgkin's disease and non-Hodgkin lymphoma). This study included 169 cases and 338 controls. The results indicate that exposure to phenoxy acids, chlorophenols, and organic solvents may be a causative factor in malignant lymphoma. Combined exposure of these chemicals seemed to increase the risk. Exposure to various other agents was not obviously different in cases and in controls.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Axelson O. The case-referent (case-control) study in occupational health epidemiology. Scand J Work Environ Health. 1979 Jun;5(2):91–99. [PubMed]
  • Axelson O. A note on observational bias in case-referent studies in occupational health epidemiology. Scand J Work Environ Health. 1980 Mar;6(1):80–82. [PubMed]
  • Bjorkholm M, Holm G, Mellstedt H. Immunologic profile of patients with cured Hodgkin's disease. Scand J Haematol. 1977 May;18(5):361–368. [PubMed]
  • Greene MH, Brinton LA, Fraumeni JF, D'Amico R. Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet. 1978 Sep 16;2(8090):626–627. [PubMed]
  • Greim H, Bonse G, Radwan Z, Reichert D, Henschler D. Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation. Biochem Pharmacol. 1975 Nov 1;24(21):2013–2017. [PubMed]
  • Grufferman S, Duong T, Cole P. Occupation and Hodgkin's disease. J Natl Cancer Inst. 1976 Nov;57(5):1193–1195. [PubMed]
  • Gutensohn N, Cole P. Epidemiology of hodgkin's disease in the young. Int J Cancer. 1977 May 15;19(5):595–604. [PubMed]
  • Hardell L. Malignant lymphoma of histiocytic type and exposure to phenoxyacetic acids or chlorophenols. Lancet. 1979 Jan 6;1(8106):55–56. [PubMed]
  • Hardell L, Sandström A. Case-control study: soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols. Br J Cancer. 1979 Jun;39(6):711–717. [PMC free article] [PubMed]
  • Hoover R, Fraumeni JF., Jr Risk of cancer in renal-transplant recipients. Lancet. 1973 Jul 14;2(7820):55–57. [PubMed]
  • Infante PF, Rinsky RA, Wagoner JK, Young RJ. Leukaemia in benzene workers. Lancet. 1977 Jul 9;2(8028):76–78. [PubMed]
  • Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. [PMC free article] [PubMed]
  • Lenner P, Lundgren E, Damber L. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification. Acta Radiol Oncol Radiat Phys Biol. 1979;18(3):177–191. [PubMed]
  • Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed]
  • MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1189–1201. [PubMed]
  • Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969 Jun;25(2):339–355. [PubMed]
  • Miettinen OS. Estimation of relative risk from individually matched series. Biometrics. 1970 Mar;26(1):75–86. [PubMed]
  • Miettinen OS. Components of the crude risk ratio. Am J Epidemiol. 1972 Aug;96(2):168–172. [PubMed]
  • Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. [PubMed]
  • Olin GR, Ahlbom A. The cancer mortality among Swedish chemists graduated during three decades. A comparison with the general population and with a cohort of architects. Environ Res. 1980 Jun;22(1):154–161. [PubMed]
  • Seiler JP. The genetic toxicology of phenoxy acids other than 2,4,5-T. Mutat Res. 1978;55(3-4):197–226. [PubMed]
  • Seiler JP. Phenoxyacids as inhibitors of testicular DNA synthesis in male mice. Bull Environ Contam Toxicol. 1979 Jan;21(1-2):89–92. [PubMed]
  • Vainio H, Päkkönen R, Rönnholm K, Raunio V, Pelkonen O. A study on the mutagenic activity of styrene and styrene oxide. Scand J Work Environ Health. 1976 Sep;2(3):147–151. [PubMed]
  • Vianna NJ, Polan A. Lymphomas and occupational benzene exposure. Lancet. 1979 Jun 30;1(8131):1394–1395. [PubMed]
  • Vigliani EC, Forni A. Benzene and leukemia. Environ Res. 1976 Feb;11(1):122–127. [PubMed]
  • Vos JG, Moore JA, Zinkl JG. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals. Environ Health Perspect. 1973 Sep;5:149–162. [PMC free article] [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK